SHARESIFT
Healthcare · data ~15-min delayed
116.34 CHF -1.46%
| Price | 116.34 CHF |
| Day change | -1.46% |
| Market cap | 221.13B |
| 52-week range | 97.05 – 132.68 |
| P/E (trailing) | 21.0 |
| Dividend yield | 3.18% |
| Payout ratio | 69.86% |
| Return on equity | 30.35% |
| Debt / equity | 117% |
| Beta | 0.49 |
| Sector | Healthcare |
| Value score | 37 / 100 |
How the value score is calculated: 13 published tests, weighted to 100.
Novartis AG (NOVN.SW) scores 37/100 on this site's value model, in the lower band: most of the valuation measures it checks sit on the richer side. It trades at 21.0 times trailing earnings and is classified in Healthcare. The dividend yield is 3.18%, paid from 70% of earnings. Return on equity is 30%, with debt at 117% of equity. On its filings it passes 8 of the nine Piotroski checks, which points to improving fundamentals. These are automated readings of reported figures, not a recommendation.
Piotroski F-Score 8 / 9 — nine pass/fail checks on profitability, leverage and efficiency, comparing the latest financial year with the one before.
Updated · prices ~15-min delayed, fundamentals as last reported
Open full interactive analysis →Value scoring · Piotroski F-Score · Altman Z · technicals · dividends — free, no sign-up.